Cargando…
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers
It was reported that lumican inhibits the activity of metalloproteinase MMP-14 and melanoma cell migration in vitro and in vivo. Moreover, Snail triggers epithelial-to-mesenchymal transition and the metastatic potential of cancer cells. Therefore, the aim of this study was to examine the effect of l...
Autores principales: | Karamanou, Konstantina, Franchi, Marco, Proult, Isabelle, Rivet, Romain, Vynios, Demitrios, Brézillon, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068222/ https://www.ncbi.nlm.nih.gov/pubmed/33917849 http://dx.doi.org/10.3390/cells10040841 |
Ejemplares similares
-
Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition
por: Karamanou, Konstantina, et al.
Publicado: (2017) -
Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity
por: Stasiak, Marta, et al.
Publicado: (2016) -
Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach
por: Dauvé, Jonathan, et al.
Publicado: (2021) -
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
por: Jeanne, Albin, et al.
Publicado: (2017) -
Label-Free Infrared Spectral Histology of Skin Tissue Part I: Impact of Lumican on Extracellular Matrix Integrity
por: Nannan, Lise, et al.
Publicado: (2020)